Skip to main content

Advertisement

Table 1 Patient’s characteristics at baseline (n=18)

From: Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy

Characteristics EG n (%) CG p-values
Subjects 12 (52 %) 11 (48 %)  
Dropouts 3 (13 %) 2 (9 %)  
Compliants 9 (39 %) 9 (39 %)  
Gender    .578
Female 2 (11 %) 1 (6 %)  
Male 7 (39 %) 8 (44 %)  
Etiology    1.000
Hemorrhagic 1 (6 %) 3 (17 %)  
Ischemic 8 (44 %) 6 (33 %)  
Lesion side    1.000
Right 5 (28 %) 4 (22 %)  
Left 4 (22 %) 5 (28 %)  
Mean (SD) - Median  
[25th–75th percentiles]  
Age, years 63.40 (9.40) – 63 54.80 (12.00) – 57 .154
  [57.80–68.50] [50.80–63.30]  
Days 1298.44 (1968.48) – 400 1387.33 (1455.12) – 735 .232
poststroke [269.25–1373.00] [493.50 – 1826.00]  
Clinical scales    
Total UE-FM 32.33 (16.09) – 38 36.89 (12.29) – 40 .651
  [25.50–40.75] [50.80–63.30]  
UE-FM-Proximal 17.00 (7.40) – 17 18.89 (6.01) – 19 .88
  [12.50–21.50] [16.88–21.13]  
UE-FM-Wrist 5.78 (3.60) – 8 4.78 (3.31) – 5 .49
  [5.75–10.25] [2.25–7.75]  
UE-FM-Hand 7.44 (4.69) – 8 11.44 (4.72) – 12 .15
  [4.63–11.38] [8.50–15.50]  
UE-FM- 2.56 (1.67) – 3 2.78 (1.30) – 3 .99
Coordination [1.75–4.25] [2.00–4.00]  
CAHAI 32.56 (14.47) – 36 36.89 (12.29) – 40 .475
  [25.50–42.25] [16.00–45.00]  
BI 85.33 (10.82) – 88 90.56 (7.32) – 90 .445
  [80.00–91.00] [84.00–96.25]  
Hamilton 14.44 (9.61) – 8 12.44 (9.10) – 10 .649
  [6.75–24.75] [5.50–19.50]  
  1. Statistical test used for p-value: Wilcoxon rank-sum test